Sustained Pain Relief with Dihydroergotamine in Migraine Is Potentially Due to Persistent Binding to 5-HT1B/1D Receptors

P7

  • Kori, S.
  • Zhang, J.
  • Kellerman, D.
  • Armer, T.
  • Goadsby, P. J.

  • 1MAP Pharmaceuticals, Inc., Mountain View, CA, USA;2Headache Research Group, University of California, San Francisco, San Francisco, CA, USA.

Headache 52(5):p 874-875, May 2012.
Copyright © 2012 Blackwell Publishing Ltd.
View full text|Download PDF